Justices Ask SG To Weigh In On GSK, Classen Patent Row

Law360, New York (June 25, 2012, 1:29 PM ET) -- The U.S. Supreme Court on Monday invited the U.S. solicitor general to weigh in on Classen Immunotherapies Inc.'s dispute with GlaxoSmithKline PLC over Classen's patents for evaluating a vaccine immunization schedule.

The high court asked Solicitor General Donald B. Verrilli Jr. to file a brief in the case expressing the views of the U.S. government, according to the one-sentence order.

The Supreme Court handed down the order without comment.

GSK lodged a petition for a writ of certiorari on Feb. 28, pushing for review of a...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required